JA

Junaid Ahmed Jameel Ahmed Shaikh

Active Director Director DIN 09653288
DIN 09653288 First appointment Jun 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Junaid Ahmed Jameel Ahmed Shaikh

Data last updated:

Junaid Ahmed Jameel Ahmed Shaikh is a Director at Trumed Pharmaceutical Private Limited (since 2022). The company operates in Pharma.

DIN 09653288
Primary Designation Director
Industry Pharma
First Appointment 27 Jun 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Jun 20222022Active

Board colleagues of Junaid Ahmed Jameel Ahmed Shaikh

NameDINCompanyDesignation
Ram Narayan Galakate09653287Trumed Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Trumed Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Junaid Ahmed Jameel Ahmed Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Junaid Ahmed Jameel Ahmed Shaikh

Junaid Ahmed Jameel Ahmed Shaikh currently holds 1 directorship: Trumed Pharmaceutical Private Limited (Director, since 27 Jun 2022).

Junaid Ahmed Jameel Ahmed Shaikh was first appointed on 27 Jun 2022 as Director at Trumed Pharmaceutical Private Limited.

The current boards of Junaid Ahmed Jameel Ahmed Shaikh's companies include Ram Narayan Galakate (Trumed Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available